CJ Corporation to invest 32.0 billion won into Hanil Pharm

Published: 2004-04-19 06:57:00

Updated: 2004-04-19 06:57:00

Hanil Pharm announced on April 13 that its board of directors will hold its special meeting on April 30 to resolve the expected investment of 32.0 billion won from CJ Consortium, saying that the investment will be made in the form of issuing new shares to redeem the liabilities.

Hanil noted th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK